key: cord-0847763-c544jhv9
authors: Girard, Noémie; Odille, Geoffrey; Sanchez, Stéphane; Lelarge, Sarah; Mignot, Alexandre; Putot, Sophie; Larosa, Fabrice; Vovelle, Jérémie; Nuss, Valentine; Da Silva, Sofia; Barben, Jérémy; Manckoundia, Patrick; Putot, Alain
title: Comment on: “Beyond Chronological Age: Frailty and Multimorbidity Predict In-hospital Mortality in Patients With Coronavirus Disease 2019”
date: 2021-01-08
journal: J Gerontol A Biol Sci Med Sci
DOI: 10.1093/gerona/glab005
sha: 7f41ab147a01d64ff9db00ea345066f3335bf4fe
doc_id: 847763
cord_uid: c544jhv9

nan

Dear Editor, We read with great interest the article by Alessandra Marengoni et al., evaluating whether frailty and multimorbidity predict in-hospital mortality in patients with COVID-19 beyond chronological age (1) . This interesting question has been on the mind of every physician providing acute medical care to older COVID-19 patients during what has been the most deadly outbreak in the world since Spanish Influenza in 1918. Compared with younger patients, older patients are disproportionately affected and at a much higher risk of mortality: The fatality rate is evaluated at up to 30% in patients aged over 80 years compared with up to 5% in the population as a whole (2) . Previous observational studies report that older age and comorbidities are associated with a higher rate of mortality (3-7).

However, whether older age is an independent predictor of in hospital mortality after careful adjustment on comorbidities and frailty remains a matter of debate. As highlighted by Marengoni et al., the frequent use of chronological age in decision-making for questions that may include access to intensive care, poses serious ethical problems in the absence of solid evidence in support of such decisions (8) . From their observational data on 165 hospitalized patients, the authors conclude that frailty and multimorbidity are independent predictors of mortality and should therefore be assessed, and not only chronological age. They consider that these 2 conditions are worth embedding in the decision-making process for COVID-19 patients.

In this context, observational studies assessing the respective prognostic weight of comorbidities, frailty, and age in geriatric setting are particularly welcome. Notably, Mendes et al. recently reported interesting results confirming these conclusions (9): In 235 patients hospitalized with COVID-19 with a mean age of 86 years, frailty, comorbidities, and functional status, but not age per se, were independent risk factors for mortality.

In a multicenter observational study of patients aged > 75 years in COVID-19 geriatric units of 4 hospitals in Burgundy, one of the most affected regions in France, we sought to confirm such findings. We therefore included all consecutive patients aged > 75 years and hospitalized for COVID-19 (with positive RT-PCR test). Clinical presentation, comorbidities, and dependence were recorded at admission. The World Health Organization (WHO) severity score was evaluated at admission according to current guidelines (10) . Factors associated with 1-month mortality were evaluated in univariate and multivariate analyses using a Cox regression model. This study was approved by the local ethics committee.

We included 142 consecutive patients with a median age of 86 years, and each patient was followed up for 1 month after admission. Overall, 48 (33.8%) patients had died by the end of follow-up. As shown in Table 1 In conclusion, these findings support Marengoni's proposal that comorbidities should be considered in the decision-making process for older COVID-19 patients more than chronological age alone. Moreover, the short-term prognosis is above all driven by the acute clinical presentation, even in frail older adults. Note: ADL = Activity of daily living; DBP = Diastolic blood pressure; SBP = Systolic blood pressure; WHO COVID-19 score = World Health Organization COVID-19 severity score, (10). *p < .05.

Beyond chronological age: frailty and multimorbidity predict in-hospital mortality in patients with coronavirus disease 2019

The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical characteristics and outcomes of older patients with Coronavirus disease 2019 (COVID-19) in Wuhan, China: a single-centered, retrospective study

Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank community cohort

Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with Coronavirus disease 2019 in geriatric care

AGS Position statement: resource allocation strategies and age-related considerations in the COVID-19 era and beyond

Predictors of in-hospital mortality in older patients with COVID-19: the COVIDAge study

WHO Guideline Development Group for Clinical Management of COVID-19. Clinical management of COVID-19

The authors thank Suzanne Rankin for the English review of the manuscript.